Glucose meters are coming under renewed scrutiny - off-label use with critcally ill patients, infection issues, and new draft guidelines for tighter requirements for FDA clearance. We take a look at a current glucose meter to see if current performance is meeting today's goals - and possibly tomorrow's...
An analysis of 5 different point-of-care (POC) analyzers for C-Reactive Protein (CRP). Many years ago, assays were considered to be too imprecise to support their clinical use. Are the latest instruments any better?
A 2013 study evaluated the analytical performance of a POC blood analysis system. Are we seeing improvements in POC performance? Are there additional sources of error that need to be tracked when we evaluate POC devices?
As part of our continuing series of evaluations, we take a look at three point-of-care (POC) blood glucose analyzers. We use a paper that evaluates them for use in a specific critical setting: a neonatal intensive care unit.